GlaxoSmithKline S.A.E (EGX: BIOC)

GlaxoSmithKline S.A.E Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,524	2,969	3,187	2,579	1,416	1,650
Market Cap Growth	-9.55%	-6.84%	23.58%	82.08%	-14.17%	0%
Enterprise Value	3,482	2,758	2,079	2,840	1,603	1,634
Last Close Price	42.20	34.64	33.60	26.28	14.24	16.10
PE Ratio	26.41	47.85	3.82	14.19	42.28	9.43
PS Ratio	1.36	1.33	1.75	1.42	0.71	0.97
PB Ratio	1.84	1.51	1.84	1.90	1.17	1.36
P/FCF Ratio	50.86	13.18	3.23	16.49	-25.83	-8.43
P/OCF Ratio	15.12	9.82	3.08	13.42	-1208.52	-26.38
EV/Sales Ratio	1.34	1.23	1.14	1.57	0.80	0.96
EV/EBITDA Ratio	5.60	5.80	42.79	10.20	6.94	5.68
EV/EBIT Ratio	6.09	6.25	135.67	11.73	7.92	6.11
EV/FCF Ratio	50.24	12.25	2.11	18.15	-29.24	-8.35
Debt / Equity Ratio	0.07	0.05	0.04	0.13	0.12	0.19
Debt / EBITDA Ratio	0.20	0.20	1.07	0.60	0.63	0.82
Debt / FCF Ratio	1.90	0.43	0.07	1.15	-2.66	-1.20
Asset Turnover	0.75	0.66	0.65	0.80	0.89	0.77
Inventory Turnover	1.35	2.46	2.57	2.31	3.14	2.79
Quick Ratio	0.44	1.01	0.95	0.73	0.58	1.00
Current Ratio	1.75	1.88	1.76	1.53	1.44	1.59
Return on Equity (ROE)	6.95%	3.27%	-7.38%	12.03%	2.32%	12.42%
Return on Assets (ROA)	10.94%	8.18%	0.34%	6.66%	5.62%	7.58%
Return on Capital (ROIC)	18.75%	14.30%	0.57%	10.45%	9.01%	13.21%
Earnings Yield	3.79%	2.04%	23.08%	6.00%	1.99%	8.64%
FCF Yield	1.97%	7.59%	30.98%	6.07%	-3.87%	-11.86%
Dividend Yield	1.78%	2.17%	-	2.85%	-	-
Payout Ratio	31.86%	217.67%	15.10%	3.61%	19.84%	3.91%
Total Shareholder Return	1.59%	2.17%	-	2.85%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.